Aveo Pharmaceuticals (AVEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 77,398 | 70,168 | 73,846 | 70,542 | 68,840 |
| Marketable Securities | 0 | 6,992 | 5,192 | 16,784 | 25,176 |
| Receivables | 19,764 | 16,129 | 13,774 | 11,601 | 9,508 |
| Inventories | 1,106 | 1,320 | 1,694 | 1,656 | 1,252 |
| Other current assets | 706 | 894 | 734 | 1,181 | 881 |
| TOTAL | $100,731 | $97,588 | $97,726 | $104,736 | $107,977 |
| Non-Current Assets | |||||
| PPE Net | 225 | 242 | 259 | 276 | 292 |
| Other Non-Current Assets | 277 | 281 | 230 | 329 | 818 |
| TOTAL | $502 | $523 | $489 | $605 | $1,110 |
| Total Assets | $101,233 | $98,111 | $98,215 | $105,341 | $109,087 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,039 | 3,605 | 3,014 | 2,712 | 4,925 |
| Accrued Expenses | 37,382 | 22,705 | 17,282 | 15,430 | 16,018 |
| TOTAL | $42,423 | $31,497 | $20,304 | $18,731 | $22,376 |
| Non-Current Liabilities | |||||
| Long Term Debt | 27,185 | 33,247 | 38,189 | 37,960 | 33,026 |
| Deferred Revenues | N/A | 0 | N/A | 578 | 1,072 |
| Other Non-Current Liabilities | 2,780 | 2,780 | 2,780 | 2,780 | 2,451 |
| TOTAL | $29,965 | $36,027 | $40,969 | $40,740 | $35,477 |
| Total Liabilities | $72,388 | $67,524 | $61,273 | $59,471 | $57,853 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 34,763 | 34,614 | 34,478 | 34,475 | 34,374 |
| Common Shares | 35 | 35 | 34 | 34 | 34 |
| Retained earnings | -696,331 | -693,065 | -684,746 | -674,547 | -667,292 |
| Other shareholders' equity | 0 | -2 | 1 | -3 | -2 |
| TOTAL | $28,845 | $30,587 | $36,942 | $45,870 | $51,234 |
| Total Liabilities And Equity | $101,233 | $98,111 | $98,215 | $105,341 | $109,087 |